Article Type
Corrigendum
Published
The authors wish to make the following corrections to their article: Clements JN. Diabetes: how to manage chronic kidney disease. Drugs Context. 2022;11:2021-9-10. https://doi.org/10.7573/dic.2021-9-10
Corrigendum
The authors wish to make the following corrections to their article: Clements JN. Diabetes: how to manage chronic kidney disease. Drugs Context. 2022;11:2021-9-10. https://doi.org/10.7573/dic.2021-9-10
Review
This narrative review provides the most up-to-date information regarding existing and new pharmacotherapy for the management of chronic kidney disease amongst people with diabetes, specifically type 2 diabetes.
Review
This article discusses practical pharmacotherapy strategies to improve treatment outcome for alcohol use disorder.
Review
Prescribing of antidepressant treatment (ADT) for major depressive disorder (MDD) has increased substantially over the last two decades. In this paper, the authors discuss the evidence that supports the use of ADT based on FDA approvals, data from randomized controlled trials or meta-analyses and where these are not available, the authors discuss and apply theoretical pharmacodynamic principles to help guide treatment choice in MDD.